Philip J. Lee

Insider Reports History

Entity
Individual
Location
C/O Senti Biosciences, Inc., 2 Corporate Drive First Floor, South San Francisco, CA
Signature
/s/ Mike Rhee, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip J. Lee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Senti Biosciences, Inc.\ Chief Technology Officer Common Stock 936K $4.08M $4.36 Jun 8, 2022 Direct
Senti Biosciences, Inc. Chief Technology Officer Stock Option (Right to Buy) 195K Feb 1, 2023 Direct

Insider Reports Filed by Philip J. Lee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNTI Senti Biosciences, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Chief Technology Officer
SNTI Senti Biosciences, Inc.\ Jun 8, 2022 0 $0 3 Jun 15, 2022 Chief Technology Officer